These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 30615347)

  • 1. [The microbiota of intestine. The role in development of various pathologies].
    Kuznetsova EE; Gorokhova VG; Bogorodskaya SL
    Klin Lab Diagn; 2016 Oct; 61(10):723-6. PubMed ID: 30615347
    [No Abstract]   [Full Text] [Related]  

  • 2. [Microbiota and obesity].
    Karney A
    Dev Period Med; 2017; 21(3):203-207. PubMed ID: 29077559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Akkermansia muciniphila: key player in metabolic and gastrointestinal disorders.
    Macchione IG; Lopetuso LR; Ianiro G; Napoli M; Gibiino G; Rizzatti G; Petito V; Gasbarrini A; Scaldaferri F
    Eur Rev Med Pharmacol Sci; 2019 Sep; 23(18):8075-8083. PubMed ID: 31599433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective effect of quercetin on high-fat diet-induced non-alcoholic fatty liver disease in mice is mediated by modulating intestinal microbiota imbalance and related gut-liver axis activation.
    Porras D; Nistal E; Martínez-Flórez S; Pisonero-Vaquero S; Olcoz JL; Jover R; González-Gallego J; García-Mediavilla MV; Sánchez-Campos S
    Free Radic Biol Med; 2017 Jan; 102():188-202. PubMed ID: 27890642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Physiological patterns of intestinal microbiota. The role of dysbacteriosis in obesity, insulin resistance, diabetes and metabolic syndrome].
    Halmos T; Suba I
    Orv Hetil; 2016 Jan; 157(1):13-22. PubMed ID: 26708682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of intestinal microbiota in the pathogenesis of metabolic diseases.
    Węgielska I; Suliburska J
    Acta Sci Pol Technol Aliment; 2016; 15(2):201-211. PubMed ID: 28071010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insights into the role of the microbiome in obesity and type 2 diabetes.
    Hartstra AV; Bouter KE; Bäckhed F; Nieuwdorp M
    Diabetes Care; 2015 Jan; 38(1):159-65. PubMed ID: 25538312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gut microbiota and type 2 diabetes mellitus.
    Muñoz-Garach A; Diaz-Perdigones C; Tinahones FJ
    Endocrinol Nutr; 2016 Dec; 63(10):560-568. PubMed ID: 27633134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The secret world of the microbiom. Do bacteria make us fat?].
    Stiefelhagen P
    MMW Fortschr Med; 2014 May; 156(10):26. PubMed ID: 24930219
    [No Abstract]   [Full Text] [Related]  

  • 10. Fecal microbiota transplantation in metabolic syndrome: History, present and future.
    de Groot PF; Frissen MN; de Clercq NC; Nieuwdorp M
    Gut Microbes; 2017 May; 8(3):253-267. PubMed ID: 28609252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The Cutting-edge of Medicine; Human gut microbiome and its implication in endocrinology and metabolism].
    Irie J; Itoh H
    Nihon Naika Gakkai Zasshi; 2014 Nov; 103(11):2813-9. PubMed ID: 27522824
    [No Abstract]   [Full Text] [Related]  

  • 12. Functional interactions between the gut microbiota and host metabolism.
    Tremaroli V; Bäckhed F
    Nature; 2012 Sep; 489(7415):242-9. PubMed ID: 22972297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Metabolic Role of the Microbiome: Implications for NAFLD and the Metabolic Syndrome.
    Quigley EM; Abu-Shanab A; Murphy EF; Stanton C; Monsour HP
    Semin Liver Dis; 2016 Sep; 36(4):312-316. PubMed ID: 27997970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitamin D signaling maintains intestinal innate immunity and gut microbiota: potential intervention for metabolic syndrome and NAFLD.
    Zeng Y; Luo M; Pan L; Chen Y; Guo S; Luo D; Zhu L; Liu Y; Pan L; Xu S; Zhang R; Zhang C; Wu P; Ge L; Noureddin M; Pandol SJ; Han YP
    Am J Physiol Gastrointest Liver Physiol; 2020 Mar; 318(3):G542-G553. PubMed ID: 31984787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diet-induced dysbiosis of the intestinal microbiota and the effects on immunity and disease.
    Brown K; DeCoffe D; Molcan E; Gibson DL
    Nutrients; 2012 Aug; 4(8):1095-119. PubMed ID: 23016134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gut microbiota, obesity and metabolic disorders.
    Federico A; Dallio M; DI Sarno R; Giorgio V; Miele L
    Minerva Gastroenterol Dietol; 2017 Dec; 63(4):337-344. PubMed ID: 28927249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microbiome response to diet: focus on obesity and related diseases.
    Delzenne NM; Rodriguez J; Olivares M; Neyrinck AM
    Rev Endocr Metab Disord; 2020 Sep; 21(3):369-380. PubMed ID: 32691288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic regulation mechanism of fucoidan via intestinal microecology in diseases.
    Sun T; Xue M; Yang J; Pei Z; Zhang N; Qin K; Liang H
    J Sci Food Agric; 2021 Aug; 101(11):4456-4463. PubMed ID: 33682122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dysbiotic events in gut microbiota: impact on human health.
    Schippa S; Conte MP
    Nutrients; 2014 Dec; 6(12):5786-805. PubMed ID: 25514560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Connecting the Dots Between Inflammatory Bowel Disease and Metabolic Syndrome: A Focus on Gut-Derived Metabolites.
    Verdugo-Meza A; Ye J; Dadlani H; Ghosh S; Gibson DL
    Nutrients; 2020 May; 12(5):. PubMed ID: 32429195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.